Australia markets closed

IDEAYA Biosciences, Inc. (IDYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
41.17+0.53 (+1.30%)
At close: 04:00PM EDT
41.04 -0.13 (-0.32%)
After hours: 05:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.08B
Enterprise value 2.38B
Trailing P/E N/A
Forward P/E 4.65
PEG ratio (5-yr expected) N/A
Price/sales (ttm)168.29
Price/book (mrq)3.29
Enterprise value/revenue 153.47
Enterprise value/EBITDA -5.02

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 389.91%
S&P500 52-week change 326.43%
52-week high 347.74
52-week low 320.68
50-day moving average 342.50
200-day moving average 334.66

Share statistics

Avg vol (3-month) 3686.02k
Avg vol (10-day) 3626.94k
Shares outstanding 575.69M
Implied shares outstanding 675.69M
Float 874.83M
% held by insiders 11.11%
% held by institutions 1104.39%
Shares short (15 Apr 2024) 49.83M
Short ratio (15 Apr 2024) 414.7
Short % of float (15 Apr 2024) 414.92%
Short % of shares outstanding (15 Apr 2024) 413.15%
Shares short (prior month 15 Mar 2024) 48.82M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,026.55%

Management effectiveness

Return on assets (ttm)-15.00%
Return on equity (ttm)-20.31%

Income statement

Revenue (ttm)15.51M
Revenue per share (ttm)0.24
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -156.66M
Net income avi to common (ttm)-128.89M
Diluted EPS (ttm)-2.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)698.77M
Total cash per share (mrq)9.23
Total debt (mrq)2.41M
Total debt/equity (mrq)0.26%
Current ratio (mrq)28.42
Book value per share (mrq)12.51

Cash flow statement

Operating cash flow (ttm)-131.19M
Levered free cash flow (ttm)-88.05M